Evidence map›Paper›PMID 2293913›Full record

ArticleClinical & experimental metastasis

Expression of a specific protein in spontaneously metastatic fibrosarcoma cell lines and its enhanced synthesis by growth on laminin or fibronectin.

J H Youngblom, N Wang, J B McCarthy, M Janatipour, T Wang, J R Sheppard, S S Panter

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J H YoungblomDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455.
N Wang
J B McCarthy
M Janatipour
T Wang
J R Sheppard
S S Panter
University of Minnesota · US

Funding

METASTASIS INHIBITION BY FIBRONECTIN-TUMOR INTERACTIONSR01CA043924 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MCCARTHY, JAMES B. · 1987 to 1993
–
MATRIX MEDIATED TUMOR CELL MIGRATION AND METASTASISR23CA039510 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MCCARTHY, JAMES B. · 1985 to 1987
–
NCI NIH HHS CA 16231NCI NIH HHS CA 39510NCI NIH HHS CA 43924
6 · The paper itself

Abstract

A panel of tumor cell lines and clones was generated by selecting for different metastatic capacity in 3AM fibrosarcoma cells. These cell lines were exposed to substrata of various purified extracellular matrix (ECM) proteins and labeled in culture with [35S]methionine. Following analysis by two-dimensional polyacrylamide gel electrophoresis the profiles of total cellular proteins produced by the cell lines displaying different phenotypes were examined. The presence of a specific protein, p54, was related to the cellular metastatic potential, and the synthesis of p54 was influenced by growth on extracellular matrix components. The amount of p54 was minimal and non-inducible in tumor cell lines exhibiting two different phenotypes: (1) experimentally metastatic (EM) and (2) transformed, non-tumorigenic (NTT) cell types. In contrast, all of the five different cell lines capable of both spontaneous and experimental metastasis (SEM), produced p54 either constitutively or through induction by growth on ECM protein substrata of either laminin of fibronectin, but not collagen type IV. These data suggest that the p54 protein may be a unique biochemical marker associated with spontaneous metastatic cell types.

Indexed as

AnimalsCell DivisionCell LineElectrophoresis, Gel, Two-DimensionalExtracellular MatrixFibronectinsFibrosarcomaLamininMaleMiceMice, Inbred C3HNeoplasm MetastasisNeoplasm ProteinsTumor Cells, CulturedFibronectinsLamininNeoplasm Proteins

Identifiers

PMID2293913
OpenAlexW2057790862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.